Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay

Journal of Virological Methods

Volumn 78, Issue 1-2, 1999, Pages 61-70

  Weber, Bernard ^a,f   Mühlbacher, Annelies ^b   Michl, Ulrike ^b   Paggi, Giancarlo ^c   Bossi, Vincenzo ^c   Sargento, Celene ^d   Camacho, Ricardo ^e   Fall, El Hadji M Bargane ^a   Berger, Annemarie ^f   Schmitt, Urban ^g   Melchior, Walter ^g  

^a Laboratoires Reunis Kutter Lieners Hastert Centre Langwies   (Luxembourg)

^b Blutzentrale L   (Austria)

^c Laboratorio di Virologia   (Italy)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^e HOSPITAL EGAS MONIZ   (Portugal)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Human immunodeficiency virus; Multicenter evaluation; Neutralization assay

Indexed keywords

ANTIGEN P24;

ANTIGEN DETECTION; ARTICLE; AUTOMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TECHNIQUE;

ANTIBODIES, MONOCLONAL; EVALUATION STUDIES; FEMALE; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOASSAY; NEUTRALIZATION TESTS; PREGNANCY; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

HIV 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0344528639     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00162-1     Document Type: Article

References (19)

1. Aubuchon J.P., Birkmeyer J.D., Busch M.P. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion. 45:1997;45-51.
2. Baillou A., Barrin F., Allain J.-P., Petat E., Kocheleff P., Kadende P., Goudeau A. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS related disorders; a comparison between European and Central African populations. J. Infect. Dis. 156:1987;830-833.
3. M serotypes in french blood donoras over a 10-year period (1985-1995). AIDS 11, 1503-1508.
4. Borkowsky W., Krasinski K., Pollack H., Hoover W., Kaul A., Ilmet-Moore T. Early diagnosis of human immunodeficiency virus infection in children <6 months of age: comparison of polymerase chain reaction, culture, and plasma antigen capture techniques. J. Infect. Dis. 166:1992;616-619.
5. Folks T.M., Benn S., Rabson A., Theodore T., Hoggan M.D., Martin M., Lightfoote M., Sell K. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome associated retrovirus. Proc. Natl. Acad. Sci. USA. 82:1985;4539-4543.
6. Fransen K., Mertens G., Stynen D., Goris A., Nys P., Nkengasong J., Heyndrickx L., Janssens W., van der Groen G. Evaluation of a newly developed HIV antigen test. J. Med. Virol. 53:1997;31-35.
7. Garry, R.F., Fermin, C.D., 1993. Viral burden in AIDS. Nature (London) 365, 302.
8. Gürtler L.G., Hauser P.H., Eberle J., von Brunn A., Knapp S., Zekeng L., Tsague J., Kaptue L. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68:1994;1581-1585.
9. Gürtler, L., Mühlbacher, A., Michl, U., Hofmann, H., Paggi, G.G., Bossi, V., Thorstensson, R. Villaescusa, R.G., Eiras, A., Hernandez, J.H., Weber, B., 1998. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay. J. Virol. Methods 75, 27-38.
10. Maniez M., Rouzioux C., Couroucé A.M. Evaluation des trousses de dépistage de l'antigène p24 du VIH. Spectra Biol. 16:1997;41-49.
11. Mundee Y., Kamtorn N., Chaiyaphruc S et al. Infectious disease markers in blood donors in northern Thailand. Transfusion. 35:1995;264-267.
12. Murphy E.E., Korber B., Georges-Courbot M.C., You B., Pinter A., Cook D., Kieny M.P., Georges A., Mathiot C., Barré-Sinoussi F., Girard M. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic. AIDS Res. Hum. Retrovirus. 9:1993;997-1006.
13. Schmit J.Cl., Weber B. Recent advances in antiretroviral therapy and HIV infection monitoring. Intervirology. 40:1997;304-321.
14. Tersmette M., Winkel I., Groenick M., Gruters R.A., Spence R.P., Saman E., van der Groen G., Miedema F., Huisman J.G. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24 gag. Virology. 171:1989;149-155.
15. Van den Haesevelde M., Decourt J.L., Deleys R.J., Vanderborght B., van der Groen G., van Heuverswijn H., Saman E. Genomic cloning and complete sequence analysis of highly divergent African human virus isolate. J. Virol. 68:1994;1586-1596.
16. Van Kerckhoven I., Vercauteren G., Piot P., Van der Groen G. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull. WHO. 69:1991;753-760.
17. Ward J.M., Holmberg S.D., Allen Jr., Cohn D.L., Critchley S.E., Kleinmann S.H., Lenes B.A., Ravenholdt O., Davis J.R., Quinn M.G. Transmission of human immunodeficiency virus (HIV) by blood transfusion screened as negative for HIV antibody. N. Engl. J. Med. 8:1988;473-478.
18. Weber B., Melchior W., Preiser W., Hess G., Wahl M., Braner J., Doerr H.W. Quantitative detection of human immunodeficiency virus (HIV) antigen by the Enzymun-Test: comparison with alternative assays and nucleic acid sequence-based amplification of HIV type 1 RNA. J. Clin. Microbiol. 34:1996;1440-1447.
19. Weber B., Fall E.M.B., Berger A., Doerr H.W. Reduction of the diagnostic window period with new fourth generation human immunodeficiency virus screening assays. J. Clin. Microbiol. 36:1998;2235-2239.